iifl-logo

Nippon India Nifty Pharma ETF

Nippon India Nifty Pharma ETF

Fund Name

Nippon India Mutual Fund

Scheme Name

Nippon India Nifty Pharma ETF

AMC

Nippon India Mutual Fund

Type

:  Open

Category

Exchange Traded Funds (ETFs)

Launch Date

21-Jun-2021

Fund Manager

Jitendra Tolani

Net Assets (Rs. cr)

967.8

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Nippon India Nifty Pharma ETF - Nav Details

Nav Date

:  08-Jul-2025

NAV [Rs.]

:  22.6615

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nil

Nippon India Nifty Pharma ETF- NAV Chart

Nippon India Nifty Pharma ETF- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
1.55
3.32
12.01
-3.4
9.96
22.41
-
12.21
Category Avg
-0.14
1.64
17.63
6.34
4.87
20.58
21.81
15.89
Category Best
2.15
5.37
47.94
37.09
49.4
44.62
39.27
423.72
Category Worst
-2.29
-6.46
1.23
-9.33
-13.79
6.12
3.38
-25.33

Nippon India Nifty Pharma ETF- Latest Dividends

No Records Found

Nippon India Nifty Pharma ETF- Investment Details

Min. Investment(Rs.)

1000

Increm.Investment(Rs.)

0

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology22.821335569223.80
EquityDivi's Lab.Pharmaceuticals & Biotechnology10.92157270107.09
EquityCiplaPharmaceuticals & Biotechnology10.70696730104.92
EquityDr Reddy's LabsPharmaceuticals & Biotechnology9.8775423696.79
EquityLupinPharmaceuticals & Biotechnology5.9229950158.04
EquityTorrent Pharma.Pharmaceuticals & Biotechnology4.5012952844.14
EquityAurobindo PharmaPharmaceuticals & Biotechnology4.0134642639.31
EquityLaurus LabsPharmaceuticals & Biotechnology3.5848478435.13
EquityAlkem LabPharmaceuticals & Biotechnology3.366661032.89
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology3.3418653632.71
EquityMankind PharmaPharmaceuticals & Biotechnology3.3113992332.45
EquityZydus Lifesci.Pharmaceuticals & Biotechnology3.1230930530.61
EquityBioconPharmaceuticals & Biotechnology2.7074556326.51
EquityIpca Labs.Pharmaceuticals & Biotechnology2.4417213823.92
EquityAbbott IndiaPharmaceuticals & Biotechnology2.35647023.07
EquityGland PharmaPharmaceuticals & Biotechnology1.849858018.07
EquityJ B Chemicals &Pharmaceuticals & Biotechnology1.7210047616.87
EquityAjanta PharmaPharmaceuticals & Biotechnology1.375214313.42
EquityNatco PharmaPharmaceuticals & Biotechnology1.0511099510.28
EquityGranules IndiaPharmaceuticals & Biotechnology0.911796798.89
Cash & Cash Equivalent
Net CA & OthersNet CA & Others-/-0.1000.86
Reverse RepoTREPS-/-0.0700.66
Cash & Cash EquivalentC C I-/-0.0000.00

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
6,17,875.24
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart

OTHER INFORMATION

Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.